Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. (Q50856082)
Jump to navigation
Jump to search
scientific article published in February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. |
scientific article published in February 2015 |
Statements
1 reference
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. (English)
1 reference
Howard Safran
1 reference
Kevin P Charpentier
1 reference
Andreas Kaubisch
1 reference
Gregory Dubel
1 reference
Kimberly Perez
1 reference
Katherine Faricy-Anderson
1 reference
Thomas Miner
1 reference
Yoko Eng
1 reference
Joel Victor
1 reference
Angela Plette
1 reference
Joseph Espat
1 reference
Pamela Bakalarski
1 reference
Patti Wingate
1 reference
David Berz
1 reference
Denise Luppe
1 reference
Diane Martel
1 reference
Kayla Rosati
1 reference
Santiago Aparo
1 reference
1 February 2015
1 reference
38
1 reference
1-4
1 reference
1
1 reference
Identifiers
1 reference